36163 membres inscrits Accès abonné revues  Aide   Newsletter    Me connecter
Les Communiqués
 
 
     Nasdaq OMX
 
Rechercher dans le flux Nasdaq GlobeNewswire
Rechercher
Novo Nordisk submits application in the US for including data from the DEVOTE trial in the Tresiba® label
Sat, 27 05 2017 14:17:22
Bagsværd, Denmark, 27 May 2017 - Novo Nordisk today announced the submission of a supplemental application to the US Food and Drug Administration (FDA) for including data in the label for Tresiba ® (insulin degludec) from the DEVOTE (...)
Novartis receives FDA approval for expanded use of Zykadia® in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC)
Fri, 26 05 2017 19:31:17
In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival (PFS) was 16.6 months, compared to 8.1 months with chemotherapy [1]   The overall intracranial response rate in (...)
Assemblée Générale Ordinaire des Actionnaires
Fri, 26 05 2017 13:45:00
COMMUNIQUE DE PRESSE                                                                 IRVINE, CA, et HERSTAL, BELGIQUE, le 26 mai 2017, 15:45 CEST - MDxHealth SA (Euronext: MDXH.BR) a tenu aujourd'hui son Assemblée (...)
Annual General Shareholders' Meeting
Fri, 26 05 2017 13:45:00
NEWS RELEASE                                                                                         IRVINE, CA, and HERSTAL, BELGIUM - 15:45 CEST, May 26 2017 - MDxHealth SA (Euronext: MDXH.BR) held today its Annual General (...)
Inivata, in Collaboration with World- Leading Academic Centers, to Present Promising New Clinical Data on the Utility of the InVision(TM) ctDNA Platform at ASCO 2017 Annual Meeting
Fri, 26 05 2017 06:00:00
Inivata, in Collaboration with World- Leading Academic Centers, to Present Promising New Clinical Data on the Utility of the InVision(TM) ctDNA Platform across Multiple Tumor Types  at ASCO 2017 Annual Meeting (...)
ProMIS Neurosciences Chief Scientific Officer, Dr. Neil Cashman, to present at Prion 2017 International Conference
Thu, 25 05 2017 11:30:00
TORONTO and CAMBRIDGE, Mass., May 25, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:PMN), a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, announced that Neil (...)
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
Thu, 25 05 2017 11:00:00
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May, 2017: Arix (...)
Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
Thu, 25 05 2017 10:45:00
Q4 Revenue of $7.9 Billion Grew 5% as Reported; 5% at Constant Currency  Q4 GAAP Diluted EPS of $0.84; Q4 Non-GAAP Diluted EPS of $1.33 FY17 Revenue of $29.7 Billion Grew 3% as (...)
Verona Pharma Announces Further Exercise of Over-Allotment Option and Resulting Total Voting Rights
Thu, 25 05 2017 09:49:15
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD (...)
DBV Technologies : Ordinary and Extraordinary General Meeting of June 15, 2017 Procedures for Obtaining Preparatory Documents for the General Meeting
Wed, 24 05 2017 20:30:00
AMF REGULATED INFORMATION Montrouge, France, May 24, 2017 Ordinary and Extraordinary General Meeting of June 15, 2017 Procedures for Obtaining Preparatory Documents (...)
DBV Technologies : Assemblée Générale Mixte du 15 juin 2017 Modalités de mise à disposition des documents préparatoires à l'Assemblée
Wed, 24 05 2017 20:30:00
Informations Règlementées Montrouge, France, le 24 mai 2017, 10:30 p.m. CEST Assemblée Générale Mixte du 15 juin 2017 Modalités de mise à disposition des documents (...)
PCI Biotech: Disclosure of voting rights for Chairman of the Board
Wed, 24 05 2017 16:25:37
Oslo, 24 May 2017. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter  Bøhn. Hans  Peter Bøhn is chairman of PCI Biotech and shall open the annual general (...)
Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease
Wed, 24 05 2017 16:13:36
DUBLIN - May 24, 2017 - Medtronic plc (NYSE: MDT) today announced that the first patient has been enrolled in the IN.PACT(TM) AV Access Drug-Coated Balloon (DCB) study for use in patients with end-stage renal disease (ESRD). The (...)
Medtronic Chairman and CEO Omar Ishrak to Speak at Goldman Sachs Global Healthcare Conference
Wed, 24 05 2017 16:00:00
DUBLIN - May 24, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 38th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 13, 2017, in (...)
SPINEWAY :Ordinary and Extraordinary General Shareholders' Meeting of 19 June 2017 Access to preparatory documentation
Wed, 24 05 2017 15:45:00
Press release                                                                                                                                                                             Ecully, 24 May 2017 Ordinary and (...)
SPINEWAY : Assemblée Générale mixte du 19 juin 2017 Mise à disposition des documents préparatoires
Wed, 24 05 2017 15:45:00
Communiqué de presse                                                                                                                                                       Ecully, le 24 mai 2017 Assemblée Générale mixte du 19 juin 2017 (...)
Announcement from Acarix's annual general meeting
Wed, 24 05 2017 15:24:45
Announcement from Acarix's annual general meeting The annual general meeting (" AGM ") of Acarix AB (" Acarix " or the " Company ") was held today on 24 May 2017 and the following (...)
Vistin Pharma ASA : Minutes from the annual general meeting 2017
Wed, 24 05 2017 14:22:56
Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the annual general meeting held on 24 May 2017. All matters were resolved as proposed in the call for the annual general meeting. For further information, please (...)
Novo Nordisk A/S - Share repurchase programme
Wed, 24 05 2017 12:38:21
Bagsværd, Denmark, 24 May 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), also referred to (...)
ProMIS Neurosciences Designates PMN350 its Second Lead Product for Development in Alzheimer's Disease
Wed, 24 05 2017 11:30:00
TORONTO, Ontario and CAMBRIDGE, Massachusetts - May 24, 2017 - ProMIS Neurosciences (TSX:PMN), a company focused on discovery and development of precision treatments for neurodegenerative diseases, today announced that it has designated (...)
Kiadis to Host Key Opinion Leader Meeting on Addressing the Risks of Haploidentical HSCT in Blood Cancer
Wed, 24 05 2017 11:00:00
Kiadis to Host Key Opinion Leader Meeting on Addressing the Risks of Haploidentical HSCT in Blood Cancer ~ KOL meeting on 31 May in New York City with live webcast and Q&A session ~ AMSTERDAM, May 24, 2017 - Kiadis (...)
Bavarian Nordic A/S - Articles of Association
Wed, 24 05 2017 09:44:46
Updated Articles of Association for Bavarian Nordic A/S BavarianNordicArticlesofAssociation This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. (...)
Curetis Provides Update on Unyvero LRT FDA 510(k) Submission
Wed, 24 05 2017 06:06:58
Curetis Provides Update on Unyvero LRT FDA 510(k) Submission - Curetis reiterates that it expects FDA to provide decision on clearance of Unyvero LRT in the second half of 2017 Amsterdam, (...)
Xbrane Biopharma announces a directed new share issue of SEK 20 million
Wed, 24 05 2017 06:00:00
Press release 2017-05-24     Today, the Board of Directors of Xbrane Biopharma AB ("Xbrane" or the "Company"), with authorization granted by the annual general meeting held on 18 May 2017, decided to (...)
Acarix publishes the Interim Report for the period January - March 2017
Wed, 24 05 2017 06:00:00
Press release from Acarix AB (publ) 2017-05-24 Acarix publishes the Interim Report for the period January - March 2017 Today, Wednesday May 24, Acarix is publishing its interim report for the period January - March on the company (...)
publicités
publicité
 
  KauriWeb

Afficher toutes les thématiques